Seres Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Seres Therapeutics, Inc. (MCRB) reported Basic Shares Outstanding (Weighted Average) of 9.71 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 9.71M shares, a 11.01% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 9.58M shares, a 10.10% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.23M shares, a 7.76% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 8.76M shares, a 14.76% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 8.86M shares, a 14.02% increase from fiscal 2024.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 7.77M shares, a 21.40% increase from fiscal 2023.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 6.40M shares, a 94.08% decline from fiscal 2022.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 108.08M shares, a 17.86% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.71M shares 10-Q · filed 2026-08-05 | 9.64M shares 10-Q · filed 2026-08-05 | 9.51M shares derived: average of 3 quarters · filed 2026-08-05 | 9.32M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | 9.58M shares 10-Q · filed 2026-05-05 | 9.41M shares derived: average of 2 quarters · filed 2026-05-05 | 9.19M shares derived: average of 3 quarters · filed 2026-05-05 | 9.08M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | 9.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 8.99M shares derived: average of 2 quarters · filed 2026-03-12 | 8.91M shares derived: average of 3 quarters · filed 2026-08-05 | 8.86M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 8.76M shares 10-Q · filed 2025-11-05 | 8.75M shares derived: average of 2 quarters · filed 2026-08-05 | 8.74M shares 10-Q · filed 2025-11-05 | 8.69M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | 8.74M shares 10-Q · filed 2026-08-05 | 8.72M shares 10-Q · filed 2026-08-05 | 8.67M shares derived: average of 3 quarters · filed 2026-08-05 | 8.41M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | 8.70M shares 10-Q · filed 2026-05-05 | 8.63M shares derived: average of 2 quarters · filed 2026-05-05 | 8.30M shares derived: average of 3 quarters · filed 2026-05-05 | 8.12M shares derived: average of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | 8.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 8.10M shares derived: average of 2 quarters · filed 2026-03-12 | 7.92M shares derived: average of 3 quarters · filed 2026-03-12 | 7.77M shares 10-K · filed 2026-03-12 | 155.40M shares 10-K · filed 2025-03-13 | |||
| 2024-09-30 | 7.63M shares 10-Q · filed 2025-11-05 | 152.65M shares 10-Q · filed 2024-11-13 | 7.60M shares derived: average of 2 quarters · filed 2025-11-05 | 7.50M shares 10-Q · filed 2025-11-05 | 150.10M shares 10-Q · filed 2024-11-13 | -83.44M shares derived: average of 4 quarters · filed 2026-03-12 | ||
| 2024-06-30 | 7.58M shares 10-Q · filed 2025-08-06 | 151.51M shares 10-Q · filed 2024-08-13 | 7.44M shares 10-Q · filed 2025-08-06 | 148.81M shares 10-Q · filed 2024-08-13 | -113.80M shares derived: average of 3 quarters · filed 2026-03-12 | -53.28M shares derived: average of 4 quarters · filed 2026-03-12 | ||
| 2024-03-31 | 7.31M shares 10-Q · filed 2025-05-07 | 146.10M shares 10-Q · filed 2024-05-08 | -174.49M shares derived: average of 2 quarters · filed 2026-03-12 | -73.57M shares derived: average of 3 quarters · filed 2026-03-12 | -23.25M shares derived: average of 4 quarters · filed 2026-03-12 | |||
| 2023-12-31 | -356.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -114.00M shares derived: average of 2 quarters · filed 2026-03-12 | -33.43M shares derived: average of 3 quarters · filed 2026-03-12 | 6.40M shares 10-K · filed 2026-03-12 | 128.00M shares 10-K · filed 2024-03-05 | |||
| 2023-09-30 | 128.29M shares 10-Q · filed 2024-11-13 | 128.00M shares derived: average of 2 quarters · filed 2024-11-13 | 127.30M shares 10-Q · filed 2024-11-13 | 126.76M shares derived: average of 4 quarters · filed 2025-03-13 | ||||
| 2023-06-30 | 127.71M shares 10-Q · filed 2024-08-13 | 126.79M shares 10-Q · filed 2024-08-13 | 126.25M shares derived: average of 3 quarters · filed 2025-03-13 | 125.32M shares derived: average of 4 quarters · filed 2025-03-13 | ||||
| 2023-03-31 | 125.86M shares 10-Q · filed 2024-05-08 | 125.51M shares derived: average of 2 quarters · filed 2025-03-13 | 124.52M shares derived: average of 3 quarters · filed 2025-03-13 | 116.45M shares derived: average of 4 quarters · filed 2025-03-13 | ||||
| 2022-12-31 | 125.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 123.85M shares derived: average of 2 quarters · filed 2025-03-13 | 113.32M shares derived: average of 3 quarters · filed 2025-03-13 | 108.08M shares 10-K · filed 2025-03-13 | ||||
| 2022-09-30 | 122.53M shares 10-Q · filed 2023-11-02 | 107.39M shares derived: average of 2 quarters · filed 2023-11-02 | 102.38M shares 10-Q · filed 2023-11-02 | 99.70M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | 92.26M shares 10-Q · filed 2023-08-08 | 92.22M shares 10-Q · filed 2023-08-08 | 92.09M shares derived: average of 3 quarters · filed 2024-03-05 | 92.01M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | 92.16M shares 10-Q · filed 2023-05-09 | 92.01M shares derived: average of 2 quarters · filed 2024-03-05 | 91.93M shares derived: average of 3 quarters · filed 2024-03-05 | 91.86M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | 91.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 91.81M shares derived: average of 2 quarters · filed 2024-03-05 | 91.76M shares derived: average of 3 quarters · filed 2024-03-05 | 91.70M shares 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | 91.76M shares 10-Q · filed 2022-11-02 | 91.71M shares derived: average of 2 quarters · filed 2022-11-02 | 91.65M shares 10-Q · filed 2022-11-02 | 91.59M shares derived: average of 4 quarters · filed 2023-03-07 | ||||
| 2021-06-30 | 91.66M shares 10-Q · filed 2022-08-03 | 91.59M shares 10-Q · filed 2022-08-03 | 91.53M shares derived: average of 3 quarters · filed 2023-03-07 | 89.53M shares derived: average of 4 quarters · filed 2023-03-07 | ||||
| 2021-03-31 | 91.53M shares 10-Q · filed 2022-05-04 | 91.47M shares derived: average of 2 quarters · filed 2023-03-07 | 88.82M shares derived: average of 3 quarters · filed 2023-03-07 | |||||
| 2020-12-31 | 91.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 87.47M shares derived: average of 2 quarters · filed 2023-03-07 | 79.79M shares 10-K · filed 2023-03-07 | |||||
| 2020-09-30 | 83.53M shares 10-Q · filed 2021-11-10 | 75.91M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |